Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy

This cohort study examines the association of periconceptional use of glucagon-like peptide 1 (GLP-1) receptor agonists or other noninsulin second-line antidiabetic medications with increased risk of major congenital malformations.

from JAMA Internal Medicine Online First https://ift.tt/oMyRhqV